These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 7675642

  • 1. [Radioiodine therapy of funcitonal autonomy using the functional autonomous volume].
    Seeger T, Emrich D, Sandrock D.
    Nuklearmedizin; 1995 Aug; 34(4):135-40. PubMed ID: 7675642
    [Abstract] [Full Text] [Related]

  • 2. Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake.
    Reinhardt MJ, Joe A, von Mallek D, Zimmerlin M, Manka-Waluch A, Palmedo H, Krause TM.
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):480-5. PubMed ID: 11914885
    [Abstract] [Full Text] [Related]

  • 3. Radioiodine treatment of Plummer's disease.
    Moser E.
    Exp Clin Endocrinol Diabetes; 1998 Apr; 106 Suppl 4():S63-5. PubMed ID: 9867200
    [Abstract] [Full Text] [Related]

  • 4. [First results of radioiodine therapy of multifocal and disseminated thyroid gland autonomy and use of a TcTUs-adapted dose concept].
    Oexle C, Reinhardt M, Moser E.
    Nuklearmedizin; 1998 Apr; 37(6):192-6. PubMed ID: 9770712
    [Abstract] [Full Text] [Related]

  • 5. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
    Listewnik MH.
    Ann Acad Med Stetin; 2000 Apr; 46():109-21. PubMed ID: 11712298
    [Abstract] [Full Text] [Related]

  • 6. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
    Sabri O, Schulz G, Zimny M, Schreckenberger M, Zimny D, Wagenknecht G, Kaiser HJ, Dohmen BM, Bares R, Büll U.
    Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227
    [Abstract] [Full Text] [Related]

  • 7. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
    Kobe C, Eschner W, Sudbrock F, Weber I, Marx K, Dietlein M, Schicha H.
    Nuklearmedizin; 2008 May; 47(1):13-7. PubMed ID: 18278207
    [Abstract] [Full Text] [Related]

  • 8. [Reduction of thyroid volume following radioiodine therapy for functional autonomy].
    Luster M, Jacob M, Thelen MH, Michalowski U, Deutsch U, Reiners C.
    Nuklearmedizin; 1995 Apr; 34(2):57-60. PubMed ID: 7761274
    [Abstract] [Full Text] [Related]

  • 9. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L, De Palma D, Ceriani L, Vanoli P, Garancini S, Tordiglione M, Tarolo GL.
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of thyrotoxicosis with 125-iodine: results in 93 patients 3 to 5 years after treatment, and comparison with 131-iodine therapy (author's transl)].
    Glanzmann Ch, Horst W.
    Strahlentherapie; 1979 Jan; 155(1):1-5. PubMed ID: 760268
    [Abstract] [Full Text] [Related]

  • 11. [Radioiodine therapy of functional autonomy of the thyroid gland. Treatment results in view of pretreatment scintigraphic diagnosis and early response of triiodothyronine levels to treatment].
    Langhammer HR, Laubenbacher C, Hirsch C, Klingele C, Spyra JL, Senekowitsch-Schmidtke R, Schwaiger M.
    Med Klin (Munich); 1999 Aug 15; 94(8):415-24. PubMed ID: 10495620
    [Abstract] [Full Text] [Related]

  • 12. [Improved evaluation criteria of autonomous thyroid adenoma: triiodothyronine concentration in serum, functional definition through TRH test].
    Wenzel KW, Meinhold H, Schleusener H, Botsch H.
    Dtsch Med Wochenschr; 1974 Jul 05; 99(27):1465-73. PubMed ID: 4135676
    [No Abstract] [Full Text] [Related]

  • 13. Radioiodine therapy in hyperthyroid disease: poorer outcome in patients with high 24 hours radioiodine uptake.
    Kristoffersen US, Hesse B, Rasmussen AK, Kjaer A.
    Clin Physiol Funct Imaging; 2006 May 05; 26(3):167-70. PubMed ID: 16640512
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC, Zanin DE, Zweers EJ.
    Ned Tijdschr Geneeskd; 2002 Sep 28; 146(39):1837-41. PubMed ID: 12382370
    [Abstract] [Full Text] [Related]

  • 15. [Function of the thyroid gland following radio-iodine therapy in hyperthyroidism: thyroxine, triiodothyronine and TSH reaction after TRH stimulation].
    Pickardt CR, Einhäuser G, Erhardt F, Heinze HG, Horn K, Scriba PC.
    Verh Dtsch Ges Inn Med; 1976 Sep 28; 82 Pt 2():1874-7. PubMed ID: 829464
    [No Abstract] [Full Text] [Related]

  • 16. Serum T3, T4, TSH patterns in euthyroid subjects treated with 131I for thyrotoxicosis.
    Biassoni P, Bagnasco M, Caputo M, Santaniello B, Ferrini O.
    J Nucl Med Allied Sci; 1980 Sep 28; 24(1-2):93-8. PubMed ID: 7205396
    [No Abstract] [Full Text] [Related]

  • 17. What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?
    Gotthardt M, Rubner C, Bauhofer A, Berce F, Oyen WJ, Goecke J, Pfestroff A, Schlieck A, Corstens FH, Béhé M, Behr TM.
    Nuklearmedizin; 2006 Sep 28; 45(5):206-12. PubMed ID: 17043731
    [Abstract] [Full Text] [Related]

  • 18. Serum thyrotrophin and response to thyrotrophin-releasing hormone in patients who are euthyroid after radioiodine treatment for hyperthyroidism.
    Gordin A, Wägar G, Hernberg A.
    Acta Med Scand; 1973 Oct 28; 194(4):335-40. PubMed ID: 4127154
    [No Abstract] [Full Text] [Related]

  • 19. Improved dose concept for radioiodine therapy of multifocal and disseminated functional thyroid autonomy.
    Reinhardt M, Emrich D, Krause T, Bräutigam P, Nitzsche E, Blattmann H, Schümichen C, Moser E.
    Eur J Endocrinol; 1995 May 28; 132(5):550-6. PubMed ID: 7749494
    [Abstract] [Full Text] [Related]

  • 20. Radioiodine treatment of hyperthyroidism in a pregnant women.
    Berg GE, Nyström EH, Jacobsson L, Lindberg S, Lindstedt RG, Mattsson S, Niklasson CA, Norén AH, Westphal OG.
    J Nucl Med; 1998 Feb 28; 39(2):357-61. PubMed ID: 9476950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.